Life Sciences
Brook.ai secures $28 million, Counsel Health garners $25 million, OutcomesAI gets $10 million and Smartlens closed an oversubscribed $5.2 million bridge round.
Verily's platform will be used to create biomedical data pipelines and develop novel AI/ML models across key therapeutic areas.
The company offers a patient recruitment platform for clinical trials.
Data from the study revealed that chronic exposure to cortisol disrupts neuronal network activity and damages long-term potentiation, simulating stress-related cognitive decline.
The two companies will develop affordable peptide therapies aimed at extending women’s lifespan.
The funds will be used to expand operations and attract new partners.
About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.
Sanofi will implement BenchSci's Ascend across its global research organization.
The kiosks will allow patients to fill prescriptions through the Amazon app within minutes after their appointments at One Medical offices.
Developed at the University of South Australia, it could help doctors safely deprescribe obsolete medications.